Patents Represented by Attorney William E. Beaumont
  • Patent number: 8299269
    Abstract: Nor-seco-type cucurbit[n]uril compounds and methylene bridged glycoluril oligomers are produced by reacting glycoluril and formaldehyde in strong organic or mineral acid at a temperature adequate to condense the reactants. These compounds are characterized by lacking —CH2— groups rendering their internal cavities more open and, for example, more responsive to guest compounds.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: October 30, 2012
    Assignee: University of Maryland
    Inventors: Lyle David Isaacs, Wei-Hao Huang
  • Patent number: 8243420
    Abstract: A porous conducting metal oxide electrode prepared by depositing a porous conducting metal oxide film containing a conducting metal oxide film layer having a network structure of nanofibers, containing nanograins or nanoparticles, on at least one surface of a current collector, and a conducting metal oxide coating layer on the network layer of the porous conducting metal oxide through a constant current method or a cyclic voltammetric method; and a high-speed charge/discharge and ultrahigh-capacity supercapacitor using the porous conducting metal oxide electrode are provided.
    Type: Grant
    Filed: August 11, 2008
    Date of Patent: August 14, 2012
    Assignee: Korea Institute of Science and Technology
    Inventors: Il Doo Kim, Jae-Min Hong, Seong Mu Jo, Dong Young Kim
  • Patent number: 8153118
    Abstract: The invention is related to a method of altering the metabolism of a plant by carrying out the steps of treating seeds of the plant with non-genetically engineered selected mutant pink-pigmented facultative methylotroph having a plant altering capability, and growing the plants from the treated seeds, wherein the plants that grow from such treated seeds exhibit an altered characteristic relative to non-treated plants.
    Type: Grant
    Filed: February 6, 2006
    Date of Patent: April 10, 2012
    Assignees: Salisbury University, The Curators of the University of Missouri
    Inventors: Mark A. Holland, Joseph C. Polacco
  • Patent number: 8067338
    Abstract: A compound having formula (I): X—E—Si?Cl3??(I) wherein: X represents an isocyanate function; E represents a straight, branched or cyclic alkyl chain comprising from 4 to 30 carbon atoms, and optionally contains a bridge function of —O—, —S—, —NH— or aryl; and X and SiCl3 are separated by a chain of at least 4 carbon atoms.
    Type: Grant
    Filed: November 28, 2005
    Date of Patent: November 29, 2011
    Assignees: Centre National de la Recherche Scientifique, Universite de Montpellier
    Inventors: Jean-Olivier Durand, Aurore Perzyna, Nicolas Ardes-Guisot, Emmanuelle Riou, Michel Granier
  • Patent number: 8038763
    Abstract: Au—Pt heteroaggregate dendritic nanostructures and AuPt alloy nanoparticles, and their use as anodic catalysts in fuel cells.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: October 18, 2011
    Assignee: University of Maryland
    Inventors: Bryan W. Eichhorn, Shenghu Zhou, Gregory Scott Jackson
  • Patent number: 8007844
    Abstract: Process for producing a soft cheese with a natural moldy rind, the starting material being a milk, this process comprising the steps of preparing a cheese slurry, inoculation with microorganisms, ripening, heat treatment by immersing in an atmosphere saturated with steam or in a water bath. This process makes it possible to obtain a cheese which may be packaged and preserved in the form of slices.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: August 30, 2011
    Assignee: Bongrain S.A.
    Inventor: Viktor Kleinmann
  • Patent number: 7976841
    Abstract: The invention relates to the monoclonal antibody A24 directed against the transferrin receptor. This antibody is in particular useful as an antiproliferative agent.
    Type: Grant
    Filed: April 30, 2004
    Date of Patent: July 12, 2011
    Assignees: Institut National de la Sante et de la Recherche, Centre National de la Recherche Scientifique
    Inventors: Renato Monteiro, Olivier Hermine, Ivan Moura, Yves Lepelletier
  • Patent number: 7951407
    Abstract: A method of stimulating or enhancing an ornithine-urea cycle in ruminant gut tissues, which entails either feeding to a ruminant an effective amount of a ruminant feed or feed supplement containing an effective amount of a compound which stimulates activity of one or more enzymes required in the ornithine-urea cycle.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: May 31, 2011
    Assignee: University of Maryland
    Inventor: Brian James Bequette
  • Patent number: 7951564
    Abstract: A method for evaluating microsatellite instability associated with a tumour, which entails the steps of amplifying microsatellite loci in a biological sample containing genomic DNA from the tumour and determining sizes of DNA amplification products, wherein at least one microsatellite locus selected from the group consisting of NR 21, NR 22, NR 24 and NR 27, is amplified.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: May 31, 2011
    Assignee: Institut National de la Sante et de la Recherche
    Inventors: Richard Hamelin, Nirosha Suraweera
  • Patent number: 7892538
    Abstract: The invention relates to the use of a monovalent antibody fragment directed against the EC2 domain of the Fc?RI receptor for the treatment of inflammatory diseases.
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: February 22, 2011
    Assignee: Institut National de la Sante Et de la Recherche
    Inventors: Renato Monteiro, Benoît Pasquier, Ulrich Blank, Marc Benhamou, Pierre Launay, Marina Pretolani
  • Patent number: 7858118
    Abstract: An oral Tramadol-containing pharmaceutical composition suitable for once daily administration, which contains an amount of Tramadol or a pharmaceutically acceptable salt thereof, providing in vivo, a time of Tramadol peak plasma concentration (Tmax) of greater than 10 hours, and peak Tramadol plasma concentration (Cmax) which are less than three times the plasma concentration obtained 24 hours after administration (C24h) of a single dose of the composition.
    Type: Grant
    Filed: April 11, 2002
    Date of Patent: December 28, 2010
    Assignee: Galephar Pharmaceutical Research, Inc.
    Inventors: Arthur M. Deboeck, Francis Vanderbist, Antonio Sereno
  • Patent number: 7705013
    Abstract: A method of treating trypanosomiasis in a mammal, which entails administering to a mammal in need thereof an effective amount of medicinal producting comprising a plant extract comprising one or more compounds of formula (I).
    Type: Grant
    Filed: November 24, 2003
    Date of Patent: April 27, 2010
    Assignees: Institut de Recherche pour le Developpement, Universite Nationale d'Asuncion
    Inventors: Maria Elena Ferreira, Alain Fournet, Antonieta Rojas De Arias, Reynald Hocquemiller, Erwan Poupon
  • Patent number: 7678923
    Abstract: Method for synthesising 1-aryl-4-(imidazol-2-yl)-3-alkyl-1H-pyrazole derivatives from 1-aryl-3-alkyl-1H-pyrazo-line-5-one derivatives.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: March 16, 2010
    Assignee: EVULTIS
    Inventors: Alessandro Mazzola, Giovanni Sanso
  • Patent number: 7585525
    Abstract: The present invention relates to a method of processing ginseng and the uses of the extract of processed ginseng. More particularly, the present invention relates to extract of the processed ginseng which can improve the ratio of ginsenoside (Rg3+Rg5)/(Rb1+Rb2+Rc+Rd) to 10-45 due to a synergy effect by mixing ginseng with herbal drugs such as Schizandrae Fructus, Crataegi Fructus, Corni Fructus, Chaenomelis Fructus, Mume Fructus, Citrus junos, Aurantii Fructus, apples, Fructus of Punica granatum and Citrus limon, extract of saponin fraction of the processed ginseng, and a method of processing ginseng via heat treatment of the mixture of ingredients comprising the mixture of ingredients comprising ginseng and the aforementioned herbal drug(s) at a temperature of 70-120° C.
    Type: Grant
    Filed: January 2, 2003
    Date of Patent: September 8, 2009
    Assignee: Lotte Confectionery Co., Ltd.
    Inventor: Myung Hwan Park
  • Patent number: 7559607
    Abstract: An adjustable ergonomic back for a seat is disclosed. The back has a plurality of back cushions, each cushion having at least one adjustment area. It further comprises a structural shell having a plurality of voids therein. A plurality of thin flexible elements are located between the back cushions and the structural shell, each flexible element being attached to the structural shell. Each of the flexible elements has a front surface and a back surface, the front surface being in contact with a respective adjustment area of one of the plurality of back cushions. The back further has a plurality of actuators located between the flexible elements and the structural shell, each of the actuators being in contact with one of the respective back surfaces of the flexible elements and exerting a pressure on the back surface.
    Type: Grant
    Filed: December 20, 2005
    Date of Patent: July 14, 2009
    Assignee: Baultar I.D. Inc.
    Inventors: Bruno Archambault, Maxime Laplante, Michael Proulx, Claude Thérer, André Albert, Gilles Bernat, Pierre Larivière, Germain Bélanger
  • Patent number: 7521180
    Abstract: A method for evaluating microsatellite instability associated with a tumor, which entails the steps of amplifying microsatellite loci in a biological sample containing genomic DNA from the tumor and determining sizes of DNA amplification products, wherein at least one microsatellite locus selected from the group consisting of NR 21, NR 22, NR 24 and NR 27, is amplified.
    Type: Grant
    Filed: February 26, 2003
    Date of Patent: April 21, 2009
    Assignee: Institut National De La Sante Et De La Recherche
    Inventors: Richard Hamelin, Nirosha Suraweera
  • Patent number: 7517018
    Abstract: An object of the present invention is to provide a compact base for a seat with a suspension for a vehicle driver, for use in buses, heavy vehicles or special use vehicles, including excavation vehicles or foresting equipment, in which the operator or driver is subject to vibrations. The present invention provides total independence of the suspension properties, including stiffness, damping and range of travel, with height adjustment. In order to accomplish this, the compact base for the seat is divided into parts including a suspension and a seat height adjustment mechanism. These parts have no common component including balloons, dampers or guiding systems. In this manner, the suspension properties of the seat are not affected by the seat height adjustment. Moreover, the invention provides a compact seat base through the use of structures and balloons that fit one within the other.
    Type: Grant
    Filed: April 18, 2007
    Date of Patent: April 14, 2009
    Assignee: Baultar I.D. Inc.
    Inventors: Claude Therer, André Albert, Bruno Archambault, Étienne Archambault, Maxime Laplante
  • Patent number: 7435427
    Abstract: An oral pharmaceutical composition of isotretinoin containing at least two lipidic excipients, one of them being hydrophilic (i.e. having an HLB value superior or equal to 10), the other being an oily vehicle.
    Type: Grant
    Filed: September 21, 2001
    Date of Patent: October 14, 2008
    Assignee: Galephar M/F
    Inventors: Francis Vanderbist, Cecile Servais, Philippe Baudier
  • Patent number: 7435878
    Abstract: A method for altering fertility of a plant or modifying its structure is described. The method comprises, in any order, contacting the seed of the plant with Pink-Pigmented Facultative Methylotroph (PPFM) that in the aggregate produces more or less amount of cytokinin than the PPFM that was previously associated with the plant, and then planting the seed.
    Type: Grant
    Filed: May 22, 2001
    Date of Patent: October 14, 2008
    Assignee: Salisbury University
    Inventor: Mark A. Holland
  • Patent number: 7407958
    Abstract: Compounds of the formula: wherein R1, R2, R3, A1 and A2 are as defined herein, which are used advantageously in inhibiting the TGF-? and/or activin signaling pathway in mammals.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: August 5, 2008
    Assignees: SK Chemicals Co., Ltd., EWHA University Industry Collaboration Foundation
    Inventors: Dae-Kee Kim, Yung-Jue Bang, Hun-Taek Kim, Il-Sang Cho, Myoung-Soon Park, Young Jae An, Joon Hun Choi